Edgewise Therapeutics, Inc. (EWTX)
NASDAQ: EWTX · IEX Real-Time Price · USD
18.38
-1.00 (-5.16%)
Jul 2, 2024, 4:00 PM EDT - Market closed
Edgewise Therapeutics Stock Forecast
Stock Price Forecast
The 4 analysts with 12-month price forecasts for EWTX stock have an average target of 34, with a low estimate of 25 and a high estimate of 48. The average target predicts an increase of 84.98% from the current stock price of 18.38.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for EWTX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Feb '24 | Mar '24 | Apr '24 | May '24 | Jun '24 | Jul '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Buy | 3 | 4 | 4 | 4 | 4 | 3 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 4 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Piper Sandler | Piper Sandler | Buy Maintains $48 | Buy | Maintains | $48 | +161.15% | Jul 1, 2024 |
Wedbush | Wedbush | Buy Reiterates $31 | Buy | Reiterates | $31 | +68.66% | Jun 26, 2024 |
RBC Capital | RBC Capital | Buy Maintains $28 → $32 | Buy | Maintains | $28 → $32 | +74.10% | Apr 22, 2024 |
Truist Securities | Truist Securities | Strong Buy Maintains $25 | Strong Buy | Maintains | $25 | +36.02% | Apr 17, 2024 |
Wedbush | Wedbush | Buy Reiterates $26 | Buy | Reiterates | $26 | +41.46% | Apr 16, 2024 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-1.61
from -1.57
EPS Next Year
-2.03
from -1.61
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | n/a | n/a | 26.3M | 192.3M | 643.7M |
Avg | n/a | n/a | 9.4M | 107.9M | 325.4M |
Low | n/a | n/a | n/a | 43.2M | 90.1M |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | 1,948.7% | 496.7% |
Avg | - | - | - | 1,049.6% | 201.7% |
Low | - | - | - | 360.2% | -16.4% |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | -1.39 | -1.48 | -1.43 | -1.30 | -0.04 |
Avg | -1.61 | -2.03 | -1.94 | -2.01 | -0.33 |
Low | -2.16 | -2.73 | -2.61 | -2.65 | -0.83 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|---|
High | - | - | - | - | - |
Avg | - | - | - | - | - |
Low | - | - | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.